Exagen Inc Cash Flow Reinvestment Rate
Latest as of June 2026:
0.14x
Exagen Inc cash flow reinvestment rate. Exagen Inc (XGN) has a Cash Flow Reinvestment Rate of 0.14x as of June 2026, reinvesting $543.00K (capex $543.00K ) from operating cash flow of $3.99 Million. Explore Exagen Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
$543.00K
Capex + Investments
Operating Cash Flow
$3.99 Million
USD
Capital Expenditures
$543.00K
USD
Exagen Inc Cash Flow Reinvestment Rate by Year (None–None)
Exagen Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Exagen Inc. For the full cash flow conversion analysis, see Exagen Inc (XGN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow